The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Community partnerships
Culture change
Evaluation
Implementation
Implementation teams
Length of stay (LOS)
Neonatal Abstinence Syndrome (NAS)
Neonatal Opioid Withdrawal Syndrome (NOWS)
Opioid disorder
Prenatal substance use
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
06 May 2023
06 May 2023
Historique:
received:
24
03
2023
accepted:
24
04
2023
medline:
8
5
2023
pubmed:
7
5
2023
entrez:
6
5
2023
Statut:
epublish
Résumé
Neonatal Abstinence Syndrome (NAS), a problem common in newborns exposed to substances in-utero, is an emerging health concern. In traditional models of care, infants with NAS are routinely separated from their mothers and admitted to the Neonatal Intensive Care Unit (NICU) with long, expensive length of stay (LOS). Research shows a rooming-in approach (keeping mothers and infants together in hospital) with referral support is a safe and effective model of care in managing NAS. The model's key components are facilitating 24-h care by mothers on post-partum or pediatric units with support for breastfeeding, transition home, and access to Opioid Dependency Programs (ODP). This study will implement the rooming-in approach at eight hospitals across one Canadian Province; support practice and culture shift; identify and test the essential elements for effective implementation; and assess the implementation's impact/outcomes. A stepped wedge cluster randomized trial will be used to evaluate the implementation of an evidence-based rooming-in approach in the postpartum period for infants born to mothers who report opioid use during pregnancy. Baseline data will be collected and compared to post-implementation data. Six-month assessment of maternal and child health and an economic evaluation of cost savings will be conducted. Additionally, barriers and facilitators of the rooming-in model of care within the unique context of each site and across sites will be explored pre-, during, and post-implementation using theory-informed surveys, interviews, and focus groups with care teams and parents. A formative evaluation will examine the complex contextual factors and conditions that influence readiness and sustainability and inform the design of tailored interventions to facilitate capacity building for effective implementation. The primary expected outcome is reduced NICU LOS. Secondary expected outcomes include decreased rates of pharmacological management of NAS and child apprehension, increased maternal ODP participation, and improved 6-month outcomes for mothers and infants. Moreover, the NASCENT program will generate the detailed, multi-site evidence needed to accelerate the uptake, scale, and spread of this evidence-based intervention throughout Alberta, leading to more appropriate and effective care and use of healthcare resources. ClinicalTrials.gov, NCT0522662. Registered February 4
Sections du résumé
BACKGROUND
BACKGROUND
Neonatal Abstinence Syndrome (NAS), a problem common in newborns exposed to substances in-utero, is an emerging health concern. In traditional models of care, infants with NAS are routinely separated from their mothers and admitted to the Neonatal Intensive Care Unit (NICU) with long, expensive length of stay (LOS). Research shows a rooming-in approach (keeping mothers and infants together in hospital) with referral support is a safe and effective model of care in managing NAS. The model's key components are facilitating 24-h care by mothers on post-partum or pediatric units with support for breastfeeding, transition home, and access to Opioid Dependency Programs (ODP). This study will implement the rooming-in approach at eight hospitals across one Canadian Province; support practice and culture shift; identify and test the essential elements for effective implementation; and assess the implementation's impact/outcomes.
METHODS
METHODS
A stepped wedge cluster randomized trial will be used to evaluate the implementation of an evidence-based rooming-in approach in the postpartum period for infants born to mothers who report opioid use during pregnancy. Baseline data will be collected and compared to post-implementation data. Six-month assessment of maternal and child health and an economic evaluation of cost savings will be conducted. Additionally, barriers and facilitators of the rooming-in model of care within the unique context of each site and across sites will be explored pre-, during, and post-implementation using theory-informed surveys, interviews, and focus groups with care teams and parents. A formative evaluation will examine the complex contextual factors and conditions that influence readiness and sustainability and inform the design of tailored interventions to facilitate capacity building for effective implementation.
DISCUSSION
CONCLUSIONS
The primary expected outcome is reduced NICU LOS. Secondary expected outcomes include decreased rates of pharmacological management of NAS and child apprehension, increased maternal ODP participation, and improved 6-month outcomes for mothers and infants. Moreover, the NASCENT program will generate the detailed, multi-site evidence needed to accelerate the uptake, scale, and spread of this evidence-based intervention throughout Alberta, leading to more appropriate and effective care and use of healthcare resources.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov, NCT0522662. Registered February 4
Identifiants
pubmed: 37149626
doi: 10.1186/s12913-023-09440-5
pii: 10.1186/s12913-023-09440-5
pmc: PMC10164330
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
448Subventions
Organisme : CIHR
ID : RES0058392
Pays : Canada
Informations de copyright
© 2023. The Author(s).
Références
Can J Rural Med. 2018 Spring;23(2):39-44
pubmed: 29547380
Popul Health Manag. 2017 Dec;20(6):458-464
pubmed: 28409699
Children (Basel). 2021 Jun 23;8(7):
pubmed: 34201863
JAMA. 2021 Jan 12;325(2):146-155
pubmed: 33433576
Adv Neonatal Care. 2021 Feb 1;21(1):41-48
pubmed: 33278102
Children (Basel). 2022 Oct 04;9(10):
pubmed: 36291453
Semin Fetal Neonatal Med. 2019 Apr;24(2):121-132
pubmed: 30926259
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
BMC Pediatr. 2021 Nov 4;21(1):489
pubmed: 34736443
BMJ. 2018 Nov 9;363:k1614
pubmed: 30413417
Addict Sci Clin Pract. 2022 Jul 28;17(1):40
pubmed: 35902924
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Can Fam Physician. 2007 Oct;53(10):1722-30
pubmed: 17934036
Implement Sci Commun. 2022 Jul 22;3(1):80
pubmed: 35869516
Health Soc Care Community. 2022 Sep;30(5):e2264-e2276
pubmed: 34841607
Can Fam Physician. 2014 Sep;60(9):826-32
pubmed: 25217680
Int J Drug Policy. 2019 Jun;68:109-116
pubmed: 30583823
J Perinatol. 2018 Aug;38(8):1114-1122
pubmed: 29740196
Psychiatry Res. 2020 Jan;283:112467
pubmed: 31488332
Adv Neonatal Care. 2020 Dec;20(6):464-472
pubmed: 33009157
Health Soc Care Community. 2021 May;29(3):589-601
pubmed: 33713525
Obstet Gynecol. 2019 Aug;134(2):365-375
pubmed: 31306323
Neonatal Netw. 2014 Nov-Dec;33(6):307-14
pubmed: 25391589
Implement Sci. 2017 Feb 10;12(1):15
pubmed: 28187747
Adv Neonatal Care. 2021 Feb 01;21(1):32-40
pubmed: 33055519
Implement Res Pract. 2020 Oct 7;1:2633489520959072
pubmed: 37089122
J Hum Lact. 2019 May;35(2):349-353
pubmed: 30543758
J Obstet Gynecol Neonatal Nurs. 2020 Jul;49(4):373-387
pubmed: 32553592
MCN Am J Matern Child Nurs. 2021 Jul-Aug 01;46(4):211-216
pubmed: 33973889
J Pediatr Nurs. 2021 Nov-Dec;61:84-89
pubmed: 33812341
JAMA Pediatr. 2018 Apr 1;172(4):345-351
pubmed: 29404599
Paediatr Child Health. 2018 May;23(3):220-226
pubmed: 29769809
J Obstet Gynaecol Can. 2012 May;34(5):475-81
pubmed: 22555142
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Semin Perinatol. 2019 Apr;43(3):173-186
pubmed: 30773241
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
J Matern Fetal Neonatal Med. 2022 Feb;35(4):617-624
pubmed: 33047642
Am J Perinatol. 2022 Jun;39(8):897-903
pubmed: 33202425
Lancet. 2022 Feb 5;399(10324):555-604
pubmed: 35122753
BMC Med. 2019 May 7;17(1):88
pubmed: 31064388
CMAJ. 2011 Nov 22;183(17):1977-81
pubmed: 22007122
CMAJ Open. 2015 Jan 13;3(1):E55-61
pubmed: 25844370
Adv Neonatal Care. 2021 Apr 1;21(2):99-106
pubmed: 33538494
Hosp Pediatr. 2018 Jan;8(1):1-6
pubmed: 29263121
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
J Ethn Subst Abuse. 2022 Mar 3;:1-31
pubmed: 35238726
Pediatrics. 2017 Jun;139(6):
pubmed: 28562267
BMC Pregnancy Childbirth. 2020 Aug 3;20(1):441
pubmed: 32746789
Nurs Res. 2022 Jan-Feb 01;71(1):54-65
pubmed: 34596065
J Obstet Gynecol Neonatal Nurs. 2022 May;51(3):324-335
pubmed: 35341716
Nurs Womens Health. 2021 Oct;25(5):366-376
pubmed: 34478736